Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Letter: No-fault malpractice insurance

S H Rosenberg

    The New England Journal of Medicine
    |January 16, 1975
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax).

    Cell death & disease·2015
    Same author

    Bronchopulmonary dysplasia: pathway from disease to long-term outcome.

    Journal of perinatology : official journal of the California Perinatal Association·2008
    Same author

    Bcl-2 family proteins are essential for platelet survival.

    Cell death and differentiation·2007
    Same author

    New antimitotic agents with activity in multi-drug-resistant cell lines and in vivo efficacy in murine tumor models.

    Journal of medicinal chemistry·2001
    Same author

    Downregulation of Akt1 inhibits anchorage-independent cell growth and induces apoptosis in cancer cells.

    Neoplasia (New York, N.Y.)·2001
    Same author

    A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors.

    Cancer research·2001